The Impact of Medicare Low-income Subsidy on Access to Treatment, Treatment Choice, and Oncologic Outcomes in Patients With Metastatic Prostate Cancer.

Joyce, Daniel D; Qin, Xuanzi; Sharma, Vidit; Boorjian, Stephen A; Barocas, Daniel A; Dusetzina, Stacie B; Moses, Kelvin A

Joyce, Daniel D; Qin, Xuanzi; Sharma, Vidit; Boorjian, Stephen A; Barocas, Daniel A; Dusetzina, Stacie B; Moses, Kelvin A.

Afiliação

Joyce DD; Department of Urology, Mayo Clinic, Rochester, Minnesota.
Qin X; Department of Health Policy, Vanderbilt University Medical Center, Nashville, Tennessee.
Sharma V; Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center, Nashville, Tennessee.
Boorjian SA; Department of Urology, Mayo Clinic, Rochester, Minnesota.
Barocas DA; Department of Urology, Mayo Clinic, Rochester, Minnesota.
Dusetzina SB; Department of Urology, Vanderbilt University Medical Center, Nashville, Tennessee.
Moses KA; Department of Health Policy, Vanderbilt University Medical Center, Nashville, Tennessee.

J Urol ; 210(3): 447-453, 2023 09.

Article em En | MEDLINE | ID: mdl-37341420

Assuntos

Medicare Part D; Neoplasias da Próstata; Masculino; Humanos; Idoso; Estados Unidos; Neoplasias da Próstata/terapia; Pobreza; Acessibilidade aos Serviços de Saúde

Palavras-chave

Medicare Part B; Medicare Part D; androgen antagonists; financial stress; prostatic neoplasms

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Próstata / Medicare Part D Tipo de estudo: Prognostic_studies Limite: Aged / Humans / Male País/Região como assunto: America do norte Idioma: En Revista: J Urol Ano de publicação: 2023 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google